Brind.

Boston Scientific Restructures Business Segments, Appoints New COO

1 report, 1 independent Updated Oct 7
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Boston Scientific announced a reorganization of its business segments, appointing Joseph Fitzgerald as executive vice president and chief operating officer, effective January 1. Fitzgerald previously served as executive vice president and group president of cardiovascular. The company will establish three reportable business segments: Interventional Therapies, Rhythm Solutions, and MedSurg.

From wbjournal.com

Why it matters

Some supportBrind's analysis of the reports

The corporate changes are intended to speed up decision-making and assist the company in allocating investments across its product portfolio. Lance Bates will lead the Interventional Therapies segment, which includes Penumbra following the acquisition.

From wbjournal.com

Who's involved

  • Boston ScientificWorldwide developer and manufacturer of medical devices undergoing reorganization.
  • Joseph FitzgeraldAppointed executive vice president and chief operating officer of Boston Scientific.
  • Lance BatesWill lead the newly established Interventional Therapies segment.
  • Mike MahoneyServes as the Chairman and CEO of Boston Scientific.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped